Alzecure Pharma Enters Out-Licensing, Collaboration Deal With Quantumcell Aps

AlzeCure Pharma AB OMXSTO:ALZCUR:

• ALZECURE PHARMA ENTERS AN OUT-LICENSING AND COLLABORATION AGREEMENT WITH QUANTUMCELL APS FOR THE NEURORESTORE ACD856 PROJECT

• TO RECEIVE $12 MILLION UPFRONT, INCLUDING $5 MILLION DIRECT INVESTMENT AT 30% PREMIUM

• TOTAL DEAL VALUE EXCEEDS $2.2 BILLION EXCLUDING ROYALTIES